NYSE:CMDCantel Medical Stock Price, Forecast & News

$42.92

+1.75 (+4.25 %)

(As of 05/29/2020 04:00 PM ET)

Add

Compare

Today's Range

$40.31

Now: $42.92▼

$43.57

50-Day Range

$27.06

MA: $33.67▼

$42.92

52-Week Range

$20.81

Now: $42.92▼

$93.87

Volume1.28 million shs

Average Volume692,856 shs

Market Capitalization$1.83 billion

P/E Ratio85.84

Dividend Yield0.49%

Beta1.19

Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Endoscopy segment offers automated endoscope reprocessing systems; infectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets, transport systems, and mobile medical carts; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services. Its Water Purification and Filtration segment provides dialysis water purification and bicarbonate mixing systems; hollow fiber filters, and other filtration and separation products; liquid disinfectants and cold sterilization products; dry fog products; room temperature sterilization equipment and services; and clean-room certification and decontamination services for the dialysis and other healthcare, research laboratory and pharmaceutical, food and beverage, and commercial industrial customers. The company's Healthcare Disposables segment offers biological indicators, chemical integrators, sterilization pouches, towels, bibs, tray liners, sponges, nitrous oxide/oxygen sedation equipment and related single-use disposable nasal masks, face masks, and shields. It also provides hand sanitizers, germicidal wipes, disinfectants, surface disinfectants, waterline treatment products, amalgam separators, saliva ejectors, evacuator tips, plastic cups, prophy angles, and prophy paste. The company's Dialysis segment provides hemodialysis concentrates and other ancillary supplies; medical device reprocessing systems; and sterilants and disinfectants. The company sells its products through its direct distribution network in the United States; and directly or under third-party distribution agreements internationally. Cantel Medical Corp. was founded in 1963 and is headquartered in Little Falls, New Jersey.

Beat the Market (BTM) Rank^™

3.5 Analyst's Opinion

Consensus Rating
Cantel Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $65.00, Cantel Medical has a potential upside of 51.4% from its current price of $42.92.
Amount of Analyst Coverage
Cantel Medical has only been the subject of 2 research reports in the past 90 days.

2.5 Community Rank

Outperform Votes
Cantel Medical has received 209 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Cantel Medical has received 216 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Cantel Medical has received 50.82% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Cantel Medical and other stocks. Vote “Outperform” if you believe CMD will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CMD will underperform the S&P 500 over the long term. You may vote once every thirty days.

4.2 Dividend Strength

Dividend Leadership
Cantel Medical is a leading dividend payer. It pays a dividend yield of 0.49%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Cantel Medical has been increasing its dividend for 6 years.
Dividend Coverage
The dividend payout ratio of Cantel Medical is 8.86 %. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Cantel Medical will have a dividend payout ratio of 10.24 % next year. This indicates that Cantel Medical will be able to sustain or increase its dividend.

1.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cantel Medical insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 10.90% of the stock of Cantel Medical is held by insiders.
Percentage Held by Institutions
95.36% of the stock of Cantel Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9 Earnings and Valuation

Earnings Growth
Earnings for Cantel Medical are expected to grow by 69.42% in the coming year, from $1.21 to $2.05 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Cantel Medical is 85.84, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 15.35.
Price to Earnings Ratio vs. Sector
The P/E ratio of Cantel Medical is 85.84, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.26.
Price to Book Value per Share Ratio
Cantel Medical has a P/B Ratio of 2.71. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

2.61 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Surgical & medical instruments

Sub-IndustryN/A

SectorMedical

Current SymbolNYSE:CMD

Previous Symbol

CUSIPN/A

CIK19446

Webwww.cantelmedical.com

Phone973-890-7220

Debt

Debt-to-Equity Ratio1.28

Current Ratio2.15

Quick Ratio1.24

Price-To-Earnings

Trailing P/E Ratio85.84

Forward P/E Ratio35.47

P/E GrowthN/A

Sales & Book Value

Annual Sales$918.16 million

Price / Sales1.99

Cash Flow$3.53 per share

Price / Cash Flow12.16

Book Value$15.84 per share

Price / Book2.71

Profitability

EPS (Most Recent Fiscal Year)$2.37

Net Income$55.04 million

Net Margins2.02%

Return on Equity14.80%

Return on Assets6.92%

Miscellaneous

Employees2,775

Outstanding Shares42,577,000

Market Cap$1.83 billion

Next Earnings DateN/A

OptionableOptionable

Receive CMD News and Ratings via Email

Sign-up to receive the latest news and ratings for CMD and its competitors with MarketBeat's FREE daily newsletter.

Cantel Medical (NYSE:CMD) Frequently Asked Questions

How has Cantel Medical's stock been impacted by COVID-19 (Coronavirus)?

Cantel Medical's stock was trading at $49.70 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CMD stock has decreased by 13.6% and is now trading at $42.92. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Cantel Medical?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cantel Medical in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Cantel Medical.

How were Cantel Medical's earnings last quarter?

Cantel Medical Corp. (NYSE:CMD) announced its earnings results on Thursday, March, 5th. The company reported $0.61 earnings per share for the quarter, missing analysts' consensus estimates of $0.68 by $0.07. The business had revenue of $288.50 million for the quarter, compared to analyst estimates of $293.20 million. Cantel Medical had a net margin of 2.02% and a return on equity of 14.80%. View Cantel Medical's earnings history.

How often does Cantel Medical pay dividends? What is the dividend yield for Cantel Medical?

Cantel Medical announced a Semi-Annual dividend on Wednesday, December 18th. Investors of record on Friday, January 17th will be given a dividend of $0.105 per share on Friday, January 31st. The ex-dividend date of this dividend is Thursday, January 16th. This is a boost from Cantel Medical's previous Semi-Annual dividend of $0.10. View Cantel Medical's dividend history.

What price target have analysts set for CMD?

2 brokers have issued 1 year target prices for Cantel Medical's shares. Their forecasts range from $65.00 to $65.00. On average, they anticipate Cantel Medical's stock price to reach $65.00 in the next twelve months. This suggests a possible upside of 51.4% from the stock's current price. View analysts' price targets for Cantel Medical.

Has Cantel Medical been receiving favorable news coverage?

Media coverage about CMD stock has trended negative on Saturday, InfoTrie reports. The research firm ranks the sentiment of news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Cantel Medical earned a news sentiment score of -2.4 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news aboutCantel Medical.

Are investors shorting Cantel Medical?

Cantel Medical saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 3,310,000 shares, a decrease of 14.2% from the April 30th total of 3,860,000 shares. Based on an average daily volume of 688,700 shares, the days-to-cover ratio is presently 4.8 days. Currently, 8.7% of the company's shares are short sold. View Cantel Medical's Current Options Chain.

Who are some of Cantel Medical's key competitors?

Some companies that are related to Cantel Medical include Hill-Rom (HRC), Novocure (NVCR), Penumbra (PEN), Haemonetics (HAE), Globus Medical (GMED), Tandem Diabetes Care (TNDM), Integra Lifesciences (IART), Nevro (NVRO), ICU Medical (ICUI), Irhythm Technologies (IRTC), NuVasive (NUVA), Merit Medical Systems (MMSI), Inspire Medical Systems (INSP), Inovio Pharmaceuticals (INO) and AtriCure (ATRC). View all competitors.

What other stocks do shareholders of Cantel Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cantel Medical investors own include Shopify (SHOP), Adobe (ADBE), Netflix (NFLX), NVIDIA (NVDA), Alibaba Group (BABA), JPMorgan Chase & Co. (JPM), Paycom Software (PAYC), Paypal (PYPL), THERAPIX BIOSCI/S (TRPX) and Veeva Systems (VEEV).

Who are Cantel Medical's key executives?

Cantel Medical's management team includes the following people:

Mr. Charles M. Diker, Chairman and Member of Office of the Chairman (Age 84)
Mr. George L. Fotiades, Pres, CEO & Vice Chairman (Age 65)
Mr. Peter G. Clifford, Exec. VP, CFO & Member of Office of the Chairman (Age 49)
Mr. Eric W. Nodiff, Exec. VP, Gen. Counsel, Corp. Sec. & Member of Office of the Chairman (Age 62)
Mr. Seth M. Yellin, Exec. VP of Strategy & Corp. Devel. and Member of Office of the Chairman (Age 45)

What is Cantel Medical's stock symbol?

Cantel Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "CMD."

How do I buy shares of Cantel Medical?

Shares of CMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cantel Medical's stock price today?

One share of CMD stock can currently be purchased for approximately $42.92.

How big of a company is Cantel Medical?

Cantel Medical has a market capitalization of $1.83 billion and generates $918.16 million in revenue each year. The company earns $55.04 million in net income (profit) each year or $2.37 on an earnings per share basis. Cantel Medical employs 2,775 workers across the globe.

What is Cantel Medical's official website?

The official website for Cantel Medical is www.cantelmedical.com.

How can I contact Cantel Medical?

Cantel Medical's mailing address is 150 CLOVE ROAD, LITTLE FALLS NJ, 07424. The company can be reached via phone at 973-890-7220 or via email at [email protected]

This page was last updated on 5/30/2020 by MarketBeat.com Staff